Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer

  1. Cristóbal, I.
  2. Rincón, R.
  3. Manso, R.
  4. Caramés, C.
  5. Zazo, S.
  6. Madoz-Gúrpide, J.
  7. Rojo, F.
  8. García-Foncillas, J.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2015

Alea: 21

Zenbakia: 2

Orrialdeak: 347-356

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-14-0724 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus